Table 1.
Novel Therapeutic Strategies | |
---|---|
Type of Drugs | Examples |
Proteosome Inhibitors | MLN2238, Bortezomib |
Endocannabinoid/Endovanilloid Receptors Agonists | JWH-133, RTX |
Immune-Modulators | Mifamurtide |
Iron Chelators | Deferasirox, Deferoxamine, Dp44mT, Eltrombopag |
Monoclonal Antibodies | Glembatumumab-vedotin, Trastuzumab |
Tyrosine Kinase Inhibitors (TKIs) | Sorafenib, Eribulin |